William Blair Analysts Decrease Earnings Estimates for BRNS
Barinthus Biotherapeutics plc (NASDAQ:BRNS – Free Report) – Equities researchers at William Blair decreased their FY2025 earnings estimates for Barinthus Biotherapeutics in a research report issued to clients and investors on Wednesday, May 7th. William Blair analyst A. Hsieh now expects that the company will post earnings per share of ($1.63) for the year, down […]
